# Alessandro D. Santin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alessandro-d-santin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,513 |
| Field | Endometrial and Cervical Cancer Treatments |
| h-index | 72 |
| i10-index | 297 |
| Last Known Institution | Yale University |
| OpenAlex ID | https://openalex.org/A5010339370 |
| ORCID iD | https://orcid.org/0000-0003-4724-9738 |
| Works | 698 |

## Researcher papers

- [Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer](https://scholariq.org/papers/sacituzumab-govitecan-hziy-in-refractory-metastatic-triple-negative-breast/)
- [Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu](https://scholariq.org/papers/randomized-phase-ii-trial-of-carboplatin-paclitaxel-versus-carboplatin/)

## Researcher topics

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Yale University](https://scholariq.org/institutions/yale-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.